C

C3i

70 employees

Centre for Commercialization of Cancer Immunotherapy is to Accelerate the discovery, commercialization, and access to Cancer Immunotherapy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Diagnostics
Networking
regenerative medicine
Oncology
cGMP Cell Manufacturing
Cell and Gene Therapy
Innovation
Health Care
Commercialisation
Cancer Immunotherapy
Clinical Research
Stem cells
Biomarkers
Life Science

Date founded

2016

Investments made

I

Inspire Biotherapeutics Inc raised undisclosed on March 15, 2023

Investors: Octane, Ontario Institute for Regenerative Medicine and C3i

FAQ